The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus and peripheral sensory neuropathy.
 
Xindi Zhang
No Relationships to Disclose
 
Matthew R. Trendowski
No Relationships to Disclose
 
Emma Wilkinson
No Relationships to Disclose
 
Darren R. Feldman
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
David J. Vaughn
Research Funding - Astellas Pharma; Merck Sharp & Dohme; Roche/Genentech
 
Chunkit Fung
Consulting or Advisory Role - Exelixis; Novartis; Novartis
Research Funding - Astellas Pharma (Inst)
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Ipsen; Merck; Merck KGaA; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer
 
Robert A Huddart
Employment - Aspen Parkside Hopsital (I)
Leadership - Cancer clinic london Limited liability partnership
Consulting or Advisory Role - Bayer; Janssen Oncology; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - MSD; Roche
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen (Inst)
Travel, Accommodations, Expenses - Nektar; Roche/Genentech
 
Neil E. Martin
No Relationships to Disclose
 
Paul C Dinh
No Relationships to Disclose
 
Robert D. Frisina
Patents, Royalties, Other Intellectual Property - Patent Awarded for a new drug combination (hormone, anti-inflammatory) to treat age-related hearing loss. (Inst); Patent awarded for new neural stimulation technique involving laser light and gold nanoparticles (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen
 
M. Eileen Dolan
No Relationships to Disclose
 
Lois B. Travis
No Relationships to Disclose